Dr. Asculai serves as MedWound’s Vice President, R&D since July 2007. Prior to joining Mediwound, Dr. Asculai was the Senior Director of the Pharmaceutical R&D at Perrigo Israel Pharmaceuticals. In this position, he managed all pharmaceutical development activities from initiation to submission. Dr. Asculai led a considerable senior scientific and technical staff in the process of development of generic and innovative products. During his service at Perrigo, the pharmaceutical R&D specialized mainly in topical and dermatological products and became one of the world’s leading R&D groups in this field. Prior to his last position, Dr. Asculai served for nine years, in various management positions in Perrigo in Pharmaceutical R&D. Dr. Asculai holds B.Sc., M.Sc. (Summa cum Laude), Ph.D in Medical Sciences, and MBA (hons.) degrees, all from the Ben-Gurion University.